Doctors have started the first World Study of why some people with cancer overcome probabilities and survive much longer than expected.
Many cancer specialists have anecdotal stories of patients who have even overcome the most aggressive forms of the disease, although they are only given months to live.
Rosalind’s study will now bring together a large number of “survivors”, which allows scientists to look for clues about why they have responded so well to treatment, while others die.
In the past, doctors may have reduced the marked differences in the survival of luck.
But Dr. Thankamma Ajithkumar, who leads the study of the study of the United Kingdom in the hospitals of the University of Cambridge NHS Belief, said the hunt was underway for a more scientific reason.
“This is the first time someone tries to answer this question why there is a select group of people who do it exceptionally well after these terrible cancers,” he told Sky Information.
“We will have a much bigger database to say more confident than this is what makes you live longer.”
The study will focus on some of the most aggressive forms of the disease: lung cancer of small cells in extensive stage, cerebral cancer glioblastoma and ductal ducycinoma pancreatic metastatic.
Only 3% to 5% of patients are still alive five years after diagnosis.
‘I never thought I was going to die’
Katherine Webster will join the study.
It was discovered that he had a glioblastoma in stage four after suffering a seizure on a train. The scanning revealed that the tumor in his brain had about 8 cm wide.
However, after surgery and a radiotherapy and chemotherapy course, all cancer signs disappeared.
His last scan, in December, showed that he only has a small space full of liquid on the left side of his brain.
“I never thought I was going to die,” he said.
“I just remember having left surgery and saying: ‘I’m going to fight with this.’
“Having that positive psychological attitude has been really important to me.”
Katherine row regularly near where she lives in Cambridge. In addition to getting tired easily and having an occasional tremor in your hand, it is fine.
“What really surprised me was the study approach,” he said.
“It is analyzing the positive effects, why you survive instead of why you get sick, which is the regular predetermined configuration for studies these days.
“He synchronized with my disease approach.”
Scientists in more than 40 countries, including eight cancer centers in the United Kingdom, will participate in the study.
They will analyze detailed biological information of more than 1,000 patients and their tumors, comparing genetic mutations, proteins and other factors that can determine their response to treatment.
‘We could find drug goals’
Dr. Ajithkumar said: “We hope to respond to our basic curiosity of why someone is alive.
“And second, we could find a series of objectives for future drugs.”
The study is being directed by the French biotechnology startup Cure51, with the support of the Sofinnova Risk Capital firm.
Read more in Sky Information:
Surgeons eliminate the tumor through eye intake
The new test uses AI to detect breast cancer
Nicolas Wolikow, co -founder of Cure51, told Sky Information that the journal “kill cancer” target in 20 years.
“The project ambition is to eradicate cancer,” he said.
“If we could unlock these biological mechanisms that these survivors possess and reply that for most patients, I think we could do it.”
Super survivors who are interested in participating in the United Kingdom study can obtain more information in
